Form 8-K - Current report:
SEC Accession No. 0001628280-25-005983
Filing Date
2025-02-18
Accepted
2025-02-18 11:56:34
Documents
14
Period of Report
2025-02-18
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K abcl-20250218.htm   iXBRL 8-K 24081
  Complete submission text file 0001628280-25-005983.txt   175667

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abcl-20250218.xsd EX-101.SCH 2042
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abcl-20250218_def.xml EX-101.DEF 14704
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abcl-20250218_lab.xml EX-101.LAB 25092
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abcl-20250218_pre.xml EX-101.PRE 15286
17 EXTRACTED XBRL INSTANCE DOCUMENT abcl-20250218_htm.xml XML 3610
Mailing Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6
Business Address 150 W 4TH AVENUE VANCOUVER A1 V5Y 1G6 (604) 559-9005
AbCellera Biologics Inc. (Filer) CIK: 0001703057 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39781 | Film No.: 25633588
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)